| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0B | $0.7B | $0.6B | $0.6B | $0.6B | $0.1B | $0.1B | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | $0.7B | $0.5B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.4B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.6B | $0.4B | $0.3B | $0.3B | $0.3B | $0.0B | $0.0B | $0.0B |
| Net Income | $0.5B | $0.3B | $0.2B | $0.2B | $0.3B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $6.70 | $5.04 | $3.64 | $3.64 | $4.61 | $0.75 | $0.40 | $0.41 |
| EPS (Diluted) | $6.69 | $5.04 | $3.63 | $3.63 | $4.60 | $0.75 | $0.40 | $0.41 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.5B | $3.4B | $3.4B | $3.5B | $2.7B | $2.8B | $2.5B | $2.7B |
| Current Assets | $0.4B | $0.3B | $0.2B | $0.2B | $0.3B | $0.4B | $0.2B | $0.1B |
| Cash & Equivalents | $0.2B | $0.2B | $0.1B | $0.1B | $0.2B | $0.3B | $0.1B | $0.1B |
| Total Liabilities | $2.3B | $0.3B | $0.5B | $0.8B | $0.1B | $0.5B | $0.4B | $0.5B |
| Current Liabilities | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.1B |
| Stockholders' Equity | $7.2B | $3.1B | $2.9B | $2.7B | $2.5B | $2.3B | $2.1B | $2.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.5B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B |
| Investing Cash Flow | $-1.4B | $-0.1B | $-0.0B | $-0.9B | $-0.1B | $-0.2B | $-0.0B | $-0.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.8B | $-0.4B | $-0.4B | $0.5B | $-0.4B | $0.0B | $-0.2B | $-0.3B |